Clinical Trial Update: Ipilimumab and Nivolumab in Combination With Radiation Therapy in Treating Patients With Stage 2-3 Non-small Lung Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating ipilimumab and nivolumab in combination with radiation therapy for stage II-III non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• ipilimumab (ipilimumab)
• nivolumab (nivolumab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: ALK Gene Rearrangement, EGFR Gene Mutation | Phase 1 | Status: ACTIVE_NOT_RECRUITING